RENAL CELL CARCINOMA (RCC)
Clinical trials for RENAL CELL CARCINOMA (RCC) explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CARCINOMA (RCC) trials appear
Sign up with your email to follow new studies for RENAL CELL CARCINOMA (RCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug AB598 enters first human trials
Disease control OngoingThis is the first human study testing the safety of an experimental drug called AB598 in people with advanced cancers. The trial will enroll 40 participants with various cancers including lung, stomach, bladder, and breast cancer to determine safe dosage levels and monitor side e…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Engineered virus teams up with immune drugs to fight tough cancers
Disease control OngoingThis early-stage trial is testing the safety and effectiveness of a modified virus (VSV-IFNβ-NIS) when given alongside standard immunotherapy drugs (like pembrolizumab or nivolumab/ipilimumab). It is for adults with specific advanced solid tumors—including non-small cell lung can…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE1, PHASE2 • Sponsor: Vyriad, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
AI-Powered scans aim to see inside tumors like never before
Diagnosis OngoingThis study is testing whether combining two types of medical scans (PET and MRI) with artificial intelligence (AI) can more accurately determine how aggressive a solid tumor is. It involves about 135 adults with prostate cancer or other solid tumors like liver or brain cancer. Th…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Sponsor: Ciprian Catana, MD, PhD • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC
-
Blood holds clues to cancer treatment success
Knowledge-focused OngoingThis study aims to learn if simple blood tests can predict how well patients with lung or kidney cancer will respond to immunotherapy drugs. Researchers will collect blood and stool samples from 100 patients receiving standard immunotherapy treatment to look for patterns. The goa…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC